---
title: "TELA Bio, Inc. (TELA.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TELA.US.md"
symbol: "TELA.US"
name: "TELA Bio, Inc."
industry: "Health Care Supplies"
datetime: "2026-05-20T04:34:52.181Z"
locales:
  - [en](https://longbridge.com/en/quote/TELA.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TELA.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TELA.US.md)
---

# TELA Bio, Inc. (TELA.US)

## Company Overview

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | US Market |
| Website | [www.telabio.com](https://www.telabio.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:13.000Z

**Overall: C (0.57)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 28 / 45 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 13.48% |  |
| Net Profit YoY | 8.30% |  |
| P/B Ratio | -7.40 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 38498698.08 |  |
| Revenue | 80814000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -616.62% | E |
| Profit Margin | -49.30% | E |
| Gross Margin | 66.19% | A |
| Revenue YoY | 13.48% | B |
| Net Profit YoY | 8.30% | C |
| Total Assets YoY | -9.53% | E |
| Net Assets YoY | -128.70% | E |
| Cash Flow Margin | 0.00% | D |
| OCF YoY | 13.48% | B |
| Turnover | 1.10 | A |
| Gearing Ratio | 107.44% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - TELA Bio, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "13.48%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "8.30%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "-7.40",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "38498698.08",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "80814000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-616.62%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-49.30%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "66.19%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "13.48%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "8.30%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "-9.53%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-128.70%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "0.00%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "13.48%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "1.10",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "107.44%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.97 | 25/45 | - | - | - |
| PB | -7.40 | 42/45 | 27.63 | 6.77 | 4.26 |
| PS (TTM) | 0.48 | 6/45 | 0.92 | 0.66 | 0.48 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Essilor (ESLOY.US) | B | B | C | B | B | B |
| 02 | HOYA Corporation (HOCPY.US) | A | C | B | A | B | B |
| 03 | Align (ALGN.US) | B | C | B | B | C | B |
| 04 | Lantheus (LNTH.US) | A | C | B | C | C | B |
| 05 | Merit Medical (MMSI.US) | B | B | B | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-13T04:00:00.000Z

Total Analysts: **5**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 3 | 60% |
| Overweight | 1 | 20% |
| Hold | 1 | 20% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.86 |
| Highest Target | 3.25 |
| Lowest Target | 1.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/TELA.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/TELA.US/norm.md)
- [Related News](https://longbridge.com/en/quote/TELA.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/TELA.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**